Clinical Trials Browser

Recruiting × Advanced Solid Cancer × pembrolizumab × Clear all

NCT07123415 2025-11-19

A Phase 1 Study of APX-343A as Monotherapy or in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors

Phase 1 Recruiting

Other solid neoplasm

Advanced Solid Cancer